Yes, for appropriate candidates under medical supervision over several months
The dosages may be adjusted over time, and the patients response to the medication is closely monitored to achieve the best possible outcomes, with the goal of reaching a maintenance dose that supports long-term weight management success
Existing studies on neurodegenerative diseases reveal impairments related to BBB dysfunction, including compromised vascular stability, disrupted CBF, and vascular inflammation
Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Severe gastrointestinal issues Changes in mood and behavior Pancreatitis Liver problems Low blood sugar levels (hypoglycemia) Cardiac arrhythmias Suicidal ideation Major depressive disorder No adverse event of hypoglycemia or thyroid cancer was reported in Phase II trials, and 7% of retatrutide participants had skin sensitivity, compared to 1% on placebo, but these cases were not serious
Insert the needle into the BAC water vial, push in the air (to equalize pressure), and draw the correct volume of BAC water